An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma

BACKGROUND: Gut microbiome has been associated with the efficacy of immune checkpoint inhibitors (ICI) in patients with various types of cancers but not yet in hepatocellular carcinoma (HCC). AIMS: To investigate the association between gut microbiome and efficacy of ICI in patients with HCC. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ying-Chun, Lee, Pei-Chang, Kuo, Yu-Lun, Wu, Wei-Kai, Chen, Chieh-Chang, Lei, Chengh-Hau, Yeh, Ching-Ping, Hsu, Chiun, Hsu, Chih-Hung, Lin, Zhong-Zhe, Shao, Yu-Yun, Lu, Li-Chun, Liu, Tsung-Hao, Chen, Chien-Hung, Wu, Ming-Shiang, Huang, Yi-Hsiang, Cheng, Ann-Lii
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318216/
https://www.ncbi.nlm.nih.gov/pubmed/34336726
http://dx.doi.org/10.2147/JHC.S315696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318216/
https://www.ncbi.nlm.nih.gov/pubmed/34336726
http://dx.doi.org/10.2147/JHC.S315696

Ejemplares similares